Bioprospecting, access and benefit sharing: Revisiting the 'grand bargain'

Indigenous Peoples, Consent and Benefit Sharing: Lessons from the San-Hoodia Case

Volumn , Issue , 2009, Pages 69-86

  Wynberg, Rachel ^a   Laird, Sarah ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b People and Plants International   (United States)

Author keywords

A version of this article appeared in Environment, vol. 49, no. 10 (2007). Permission to reproduce parts of this article is gratefully acknowledged.; access and benefit sharing; commercial use of biodiversity; Convention on Biological Diversity; policy research and development; technology transfer traditional knowledge

Indexed keywords

EID: 84866881390     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-90-481-3123-5_5     Document Type: Chapter

References (60)

1. Anuradha, R. V. (1998). Sharing with the Kanis: A Case Study from Kerala, India. Submitted to the Conference of the Parties to the Convention on Biological Diversity, Fourth Meeting, Bratislava, Slovakia, 4-15 May.
2. Arico, S., & Salpin, C. (2005). Bioprospecting of genetic resources in the deep seabed: scientific, legal and policy aspects. Yokohama, Japan: United Nations University Institute of Advanced Studies.
3. Balick, M. J., & Cox, P. A. (1997). Plants, people and culture: the science of ethnobotany. New York: Scientific American Library.
4. CBD (2000). Annex III: Decisions Adopted by the Conference of the Parties to the Convention on Biological Diversity at Its Fifth Meeting, Nairobi, Kenya, 15-26 May. www.cbd.int/doc/decisions/COP-05-dec-en.pdf. Accessed 31 October 2008.
5. CBD (2002). Bonn Guidelines on Access to Genetic Resources and Fair and Equitable Sharing of the Benefits Arising out of Their Utilization, Secretariat of the Convention on Biological Diversity, Montreal, QC. www.cbd.int/doc/ publications/cbd-bonn-gdls-en.pdf. Accessed 31 October 2008.
6. CBD (2007a). Analysis of Gaps in Existing National, Regional, and International Legal and Other Instruments Relating to Access and Benefit Sharing. Secretariat of the Convention on Biological Diversity, draft for peer review prepared for the Ad-Hoc Open-Ended Working Group on Access and Benefit Sharing, Fifth Meeting, Montreal, QC, 8-12 October.
7. CBD (2007b). Report of the Meeting of the Group of Technical Experts on an Internationally Recognized Certificate of Origin/Source/Legal Provenance. Ad-Hoc Open-Ended Working Group on Access and Benefit Sharing of the Convention on Biological Diversity, 20 February. www.cbd.int/doc/meetings/abs/abswg-05/ official/abswg-05-07-en.pdf.
8. Chishakwe, N., & Young, T. R. (2003). Access to genetic resources, and sharing the benefits of their use: international and sub-regional issues, IUCN-The World Conservation Union. Switzerland: Gland.
9. Chouchena-Rojas, M., Ruiz Muller, M., Vivas, D., & Winkler, S. (Eds.) (2005). Disclosure requirements: ensuring mutual supportiveness between the WTO TRIPS agreement and the CBD. IUCN, Gland, Switzerland and Cambridge; ICTSD, Geneva; CIEL, Washington, DC and Geneva; IDDRI, Paris; QUNO, Geneva.
10. CIPR (2002). Chapter 4, Traditional knowledge and geographical indications. In Integrating intellectual property rights and development policy: traditional knowledge and geographical indications. Report of the Commission on Intellectual Property Rights, London. www.iprcommission.org/papers/pdfs/final- report/Ch4final.pdf. Accessed 30 October 2008.
11. Cragg, G. M., Kingston, D. G. I., & Newman, D. J. (Eds.) (2005). Anticancer agents from natural products. Boca Raton, FL: CRC Press, Taylor & Francis.
12. Crosby, A. W., Jr. (1972). The Columbian exchange: biological and cultural consequences of 1492. Westport, CT: Greenwood Press.
13. Crosby, A. W., Jr. (1986). Ecological imperialism: the biological expansion of Europe, 900-1900. Cambridge: Cambridge University Press.
14. Dobkin de Rios, M. (1992). Amazon healer. Bangalore, India: Prism Books.
15. Dutfield, G. (2002). Intellectual property rights, trade and biodiversity: seeds and plant varieties. London: Earthscan.
16. Dutfield, G. (2004) What is biopiracy? Paper presented at the International Expert Workshop on Access to Genetic Resources and Benefit Sharing, Cuernavaca, Mexico, 24-27 October. www.canmexworkshop.com/documents/ papers/I.3.pdf. Accessed 31 October 2008.
17. Dutfield, G. (2005). Disclosure of origin: time for a reality check? In M. Chouchena-Rojas, M. Ruiz Muller, D. Vivas, & S. Winkler (Eds.), Disclosure requirements: ensuring mutual supportiveness between the WTO TRIPS agreement and the CBD. IUCN, Gland, Switzerland and Cambridge; ICTSD, Geneva; CIEL, Washington, DC and Geneva; IDDRI, Paris; QUNO, Geneva.
18. Earth Negotiations Bulletin (2007). Fifth meeting of the ad-hoc open-ended working group on access and benefit sharing, 8-12 October, 2007, Montreal, Canada. www.iisd.ca/biodiv/abs5.
19. Ernst & Young (2006). Beyond borders: Global Biotechnology Report 2006. London: Ernst & Young Global Limited.
20. Gollin, M. A. (1993). An intellectual property rights framework for biodiversity prospecting. In W. V. Reid, S. A. Laird, C. A. Meyer, R. Gomez, A. Sittenfeld, D. H Janzen, M. A. Gollin, & C Juma (Eds.), Biodiversity prospecting: using genetic resources for sustainable development. World Resources Institute, Washington, DC; Instituto Nacional de Biodiversidada, Santo Domingo de Heredia, Costa Rica, FL; Rainforest Alliance, New York; African Centre for Technology Studies, Nairobi, Kenya.
21. Grove, R. H. (1996). Green imperialism: colonial expansion Tropical Island Edens and the origins of environmentalism. Cambridge: Cambridge University Press.
22. Handelsman, J. (2005). How to find new antibiotics. The Scientist, 19 (19), 20.
23. Headrick, D. R. (1990). Technological change. In B. L. Turner, W. C. Clark, R. W. Kates, J. F. Richards, J. T. Mathews & W. B. Meyer (Eds.), The earth as transformed by human action. Cambridge: Cambridge University Press.
24. Hodges, T. J., & Daniel, A. (2005). Promises and pitfalls: first steps on the road to the International ABS Regime. Review of European Community and International Environmental Law, 14 (2), 148-160.
25. Institute of Biodiversity Conservation, Ethiopian Agricultural Research Organization, Health and Performance Food International (2004). Agreement on access to, and benefit sharing from, Teff Genetic Resources. Addis Ababa, Ethiopia, December.
26. International Institute for Sustainable Development (2005). Third meeting of the ad-hoc openended working group on access and benefit sharing of the convention on biological diversity. Earth Negotiations Bulletin, 9 (310). www.iisd.ca/download/pdf/enb09310e.pdf. Accessed 31 October 2008.
27. Juma, C. (1989). The gene hunters: biotechnology and the scramble for seeds, ACTS Research Series No. 1. Nairobi, Kenya: African Centre for Technology Studies.
28. Koehn, F. E., & Carter, G. E. (2005). The evolving role of natural products in drug discovery. Nature Reviews Drug Discovery, 4 (3). www.nature.com/nrd/journal/v4/n3/pdf/nrd1657.pdf. Accessed 31 October 2008.
29. Laird, S. A. (2002). Biodiversity and traditional knowledge: equitable partnerships in practice. London: Earthscan.
30. Laird, S., Monagle, C., & Johnston, S. (2008). Queensland biodiscovery collaboration: the Griffith University AstraZeneca Partnership for natural product discovery: an access and benefit sharing case study. Yokohama, Japan: United Nations University Institute of Advanced Studies.
31. Laird, S. A., & Wynberg, R. (2006). The commercial use of biodiversity: an update on current trends in demand for access to genetic resources and benefit sharing, and industry perspectives on ABS policy and implementation. Prepared for the Ad-Hoc Open-Ended Working Group on Access and Benefit Sharing, Fourth Meeting, Granada, Spain, 30 January to 3 February.
32. Laird, S. A., & Wynberg, R. (2008). Access and Benefit Sharing in Practice: Trends in Partnerships Across Sectors. CBD Technical Series No. 38, Secretariat of the Convention on Biological Diversity, Montreal, QC. www.cbd.int/doc/publications/cbd-ts-38-en.pdf. Accessed 31 October 2008.
33. Lange, L. (2004). Tropical biodiversity: an industrial perspective. Luna, 2004 (30488) 01.
34. Lohan, D., & Johnston, S. (2003). The international regime for bioprospecting. Existing policies and emerging issues for Antarctica. Yokohama, Japan: United Nations University, Institute of Advanced Studies.
35. Macilwain, C. (1998). When rhetoric hits reality in debate on bioprospecting. Nature, 392 (6676), 535-540.
36. McAlpine, J. B., Bachmann, B. O., Piraee, M., Tremblay, S., Alarco, A., Zazopoulos, E., et al. (2005). Microbial genomics as a guide to drug discovery and structural elucidation: ECO-02301, a novel antifungal agent, as an example. Journal of Natural Products, 68 (4), 493-496.
37. McNeil, D.G. Jr (2007). Indonesia may sell, not give, bird flu virus to scientists. New York Times, 7 February.
38. Metzner, R. (Ed.) (1999). Ayahuasca: human consciousness and the spirits of nature. New York: Thunder's Mouth Press.
39. Mgbeoji, I. (2007). Lost in translation? The rhetoric of protecting indigenous peoples' knowledge in international law and the omnipresent reality of biopiracy. In P. Phillips & C. Onwuekwe (Eds.), Accessing and sharing the benefits of the genomics revolution. Dordrecht/Germany: Springer.
40. Nutrition Business Journal (2003). NBJ's Annual Industry Overview VIII. May/June.
41. Parry, B. (2004). Trading the genome: investigating the commodification of bio-information. New York: Columbia University Press.
42. PhRMA (2007). Pharmaceutical Industry Profile 2007. Pharmaceutical Research and Manufacturers of America, Washington, DC. www.phrma.org/files/ Profile%202007.pdf. Accessed 31 October 2008.
43. Reid, W. V., Laird, S. A., Meyer, C. A., Gomez, R., Sittenfeld, A., Janzen, D. H., Gollin, M. A., & Juma, C. (Eds.) (1993). Biodiversity prospecting: using genetic resources for sustainable development. World Resources Institute, Washington, DC; Instituto Nacional de Biodiversidad, Santo Domingo de Heredia, Costa Rica; Rainforest Alliance, New York; African Centre for Technology Studies, Nairobi, Kenya.
44. Rohter, L. (2007) As Brazil defends its bounty, rules ensnare scientists. New York Times, 28 August.
45. Rosenberg, D. (2007). Some business perspectives on the international regime. United Kingdom: GlaxoSmithKline.
46. Rosenthal, J. P., & Katz, F. N. (2004). Natural products research partnerships with multiple objectives in global biodiversity hotspots: nine years of the International Cooperative Biodiversity Groups Program. In A. T. Bull (Ed.), Microbial diversity and bioprospecting. Washington, DC: ASM Press.
47. Rubenstein, K. D., Heisey, P., Shoemaker, R., Sullivan, J., & Frisvold, G. (2005). Crop genetic resources: an economic appraisal. Economic Research Service Economic Information Bulletin Number 2. United States Department of Agriculture.
48. Sanchez, V., & Juma, C. (1994). Biodiplomacy: genetic resources and international relations. Nairobi, Kenya: African Centre for Technology Studies.
49. Shah, T. (2001). Trail of feathers: in search of the Birdmen of Peru. London: Phoenix.
50. Sheridan, C. (2005). EPO neem patent revocation revives biopiracy debate. Nature Biotechnology, 23, 511.
51. Smolders, W. (2005). Commercial practice in the use of plant genetic resources for food and agriculture. Background Study Paper No. 27, prepared for the Commission on Genetic Resources for Food and Agriculture, Food and Agriculture Organization of the United Nations, Rome.
52. Svarstad, H., & Dhillion, S. (2004). Responding to bioprospecting: from biodiversity in the south to medicines in the north. Oslo, Norway: Spartacus Forlag.
53. Ten Kate, K., & Laird, S. A. (1999). The commercial use of biodiversity: access to genetic resources and benefit sharing. London: Earthscan.
54. Thornstrom, C. G. (2005). The green blindness: microbial sampling in the Galapagos - the case of Craig Venter vs. the Darwin Institute and the lessons for the trip to China by 'S/V Gotheberg', unpublished manuscript.
55. Tuxill, J. (1999). Appreciating the benefits of plant biodiversity. In L. R. Brown & C. Flavin (Eds.), State of the World 1999: special millennium. London: Earthscan.
56. UN (2007). United Nations declaration on the rights of indigenous peoples. Adopted by United Nations General Assembly Resolution 61/295 on 13 September. www.un.org/esa/socdev/unpfii/documents/DRIPS-en.pdf. Accessed 29 April 2008.
57. WHO (2007). Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits. Sixtieth World Health Assembly, Agenda Item 12.1, WHA60.28, 23 May, World Health Organization.
58. Wiser, G. (2002). The Ayahuasca patent case: indigenous people's stand against misappropriation. In S. A. Laird (Ed.), Biodiversity and traditional knowledge: equitable partnerships in practice. London: Earthscan.
59. WSSD (2002). Johannesburg plan of implementation. World Summit on Sustainable Development, Johannesburg, South Africa. www.un.org/esa/sustdev/ documents/WSSD-POI-PD/English/POIToc.htm. Accessed 30 October 2008.
60. Zedan, H. (2005). Patents and biopiracy: the search for appropriate policy and legal responses, Brown Journal of World Affairs, 12 (1). www.bjwa.org/index.php?issue=12.1. Accessed 1 November 2008.